Rise Advisors’s Aehr Test Systems AEHR Stock Holding History

Rise Advisors’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-138	Closed	-$4.16K	–	125
2025 Q3	$4.16K	Hold	138	–	–	﹤0.01%	1156
2025 Q2	$1.78K	Buy	138 +88	+176%	+$838	﹤0.01%	1206
2025 Q1	$365	Buy	+50	New	+$553	﹤0.01%	1413

Other funds holding AEHR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HFF

Halter Ferguson Financial Carmel, Indiana $456M AUM 49.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Rise Advisors's AEHR Position: Q4 2025 in Review

Rise Advisors sold out of Aehr Test Systems (AEHR) in Q4 2025, closing a stake of 138 shares — an estimated $4.16K sold.

Rise Advisors first reported a position in AEHR in Q1 2025 and held it in 3 quarters. The position peaked at $4.16K in Q3 2025. 150 funds tracked by Wall St. Rank hold AEHR as of Q4 2025.

Rise Advisors reported no remaining Aehr Test Systems position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 138 Aehr Test Systems shares in Q4 2025, an estimated $4.16K.
Rise Advisors first reported a position in Aehr Test Systems in Q1 2025 and held it in 3 quarters.
Rise Advisors's Aehr Test Systems position peaked at $4.16K in Q3 2025.
150 funds tracked by Wall St. Rank held Aehr Test Systems as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.